AGC Chemicals Showcases Advanced Intermediates at CPhl North America

Published on: 

The manufacturer of glass, electronic displays, and chemical products will showcase fluorinated molecules for pharmaceutical products at the CPhI North America 2018 Exhibition.

On April 5, 2018, AGC Chemicals, a wholly owned subsidiary of Asahi Glass Company, announced that it will showcase advanced intermediates, fluorinated molecules that serve as building blocks for pharmaceutical products, at the CPhI North America Exhibition at booth 200. AGC also will feature its lines of fine micro-spherical silica gels for use in cosmetics, personal care, catalyst supports, and specialty applications.

According to AGC, its experience working with fluorine, chlorine, and iodine chemistries enables it to produce many hard-to-synthesize molecules in commercial scale. The company also provides contract development and manufacturing organization services for pharmaceutical and biopharmaceutical developers under cGMP conditions.

Features of AGC’s intermediates and ingredients for pharmaceuticals include:


  • Variety of fluorinated building blocks and fluorination technologies

  • Handling of hydrogen fluoride and F2 gas directly

  • cGMP facility and API manufacturing

  • Ultra-low temperature reactions (-100 °C)

  • High-quality C3 compounds (amines, alcohols, chlorides, etc.) and

  • Metallocene co-catalysts.

CPhI North America will take place on April 24–26, 2018 in Philadelphia, PA.

Source: AGC